Results 181 to 190 of about 585,525 (398)
Risk factors and progression of the left ventricular myocardial hypertrophy [PDF]
Tftea/mofthis workisto study the left ventricular myocardial hypertrophy. Materials and methods: In the study that was held in period from 2008 to 2013 years and covers group of 7959 workers of locomotive brigades of Transbaika-lian railway.
Lazutkina A.Yu., Gorbunov V.V.
doaj
ELECTROCARDIOGRAPHIC SIGNS OF LEFT VENTRICULAR HYPERTROPHY AND STRAIN IN HYPERTENSIVE PATIENTS [PDF]
F. O. Simpson
openalex +1 more source
Markers of progression to heart failure (HF). Gal‐4, galectin‐4; GDF‐15, growth differentiation factor 15; NT‐proBNP, N‐terminal pro‐B‐type natriuretic peptide; ST2, suppression of tumorigenicity‐2. ABSTRACT Aims Biomarkers associated with asymptomatic ventricular dysfunction might improve risk stratification and identify pathways leading to heart ...
Anna Dieden+23 more
wiley +1 more source
The Electrocardiographic Findings in Left Ventricular Hypertrophy and Dilatation [PDF]
Louis A. Soloff, John Lawrence
openalex +1 more source
Numerous T wave morphology biomarkers, which can supplement QTc assessment in long QT syndrome (LQTS), have been identified. Their diagnostic capabilities include differentiation of genotypes, identification of concealed LQTS, differentiating acquired LQTS from congenital LQTS; and determining multichannel versus hERG channel blockade.
Daniel T. Tardo+4 more
wiley +1 more source
Determinants of left ventricular hypertrophy and oxygen supply in chronic aortic valve disease. [PDF]
Roland S. Trenouth+2 more
openalex +1 more source
Load adaptation indices and concepts. An adapted RV in response to overload increases wall thickness to normalize wall stress and preserve function and morphology. If hemodynamic overload is sustained, it can progress to a maladaptive state and lead eventually to heart failure. CI, cardiac index; Ees, ventricular elastance; Ea, arterial elastance; MPAP,
Mohammad Kassar+39 more
wiley +1 more source
Myocardial ketone body oxidation contributes to empagliflozin‐induced improvements in cardiac contractility. Abstract Aims Sodium–glucose cotransporter 2 inhibitors (SGLT2i) improve cardiac performance and clinical outcomes in patients with heart failure, yet mechanisms underlying these beneficial effects remain incompletely understood.
Suzanne Nathalie Voorrips+11 more
wiley +1 more source
II. Diagnosis of Left Ventricular Hypertrophy and Myocardial Infarction from "Total" Surface Waveform Information [PDF]
F. Kornreich, D. BRISMEE
openalex +1 more source